Adenosine modulation: a novel approach to analgesia and inflammation

Bibliography

• WILLIAMS M, BURNSTOCK G: Purinergic neurotrans- mission and neuromodulation: a historical perspec-tive. In: Purinergic Approaches in Experimental Therapeutics. Jacobson KA, Jarvis MF (Eds.), Wiley-Liss, New York (1997):3–26.
   Google Scholar
• ••A recent review providing a historical perspective of thearea of purinergic transmission, PI receptor classification and nomenclature, and prototypical PI receptor ligands.
   Google Scholar
• WILLIAMS M: Adenosine: the prototypical modulator. Neurochem. Int. (1989) 14:249–264.
   PubMed Web of Science ®Google Scholar
• NEWBY AC: Adenosine and the concept of 'retaliatory metabolites'. Trends Biochem. ScL (1984) 2:42–44.
   Web of Science ®Google Scholar
• PAALZOW G, PAALZOW L: The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta Pharmacol. Toxicol. (1973) 32:22–32.
   PubMedGoogle Scholar
• HOLMGREN M, HEDNER J, MELLSTRAND T, NORDBERG G, HEDNER TH: Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. (1986) 334:290–293.
   Google Scholar
• KEIL GJ, DELANDER GE: Spinally mediated antinocicep- tion is induced in mice by an adenosine kinase, but not an adenosine deaminase inhibitor. Life ScL (1992) 51:171–176.
   Google Scholar
• •First report of the antinociceptive effects of an AK inhibitor.
   Google Scholar
• AHLIJANIAN MK, TAKEMORI AE: Effects of 0-N6-(R-phenylisopropyl)adenosine and caffeine on nocicep-tion and morphine-induced analgesia, tolerance and dependence. Eur.J. Pharmacol (1985) 112:171–179.
   PubMed Web of Science ®Google Scholar
• POON A, SAWYNOK J: Antinociception by adenosine kinase inhibitors is dependent on formalin concentra-tion. Eur. J. Pharmacol. (1995) 286:177–184.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO T, YAKSH TL: Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain (1992) 49:121–128.
   Google Scholar
• SOSNOWSKI M, YAKSH TL: Role of spinal adenosine re-ceptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth. Analg. (1989) 69:587–592.
   PubMed Web of Science ®Google Scholar
• •First report of the role of adenosine in an animal model of neuropathic pain
   Google Scholar
• LEE YL, YAKSH TL: Pharmacology of the spinal adeno-sine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J. Pharmacol. Exp. Ther. (1996) 277:1642–1648.
   PubMed Web of Science ®Google Scholar
• KARLSTEN R, GORDH T: An At-selective adenosine ago-nist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth. Analg. (1995) 80:844–847.
   PubMed Web of Science ®Google Scholar
• •Clinical case report of the effects of an Ai receptor agonist in human neuropathic pain.
   Google Scholar
• SEGERDAHL M, EKBLOM A, SOLLEVI A: The influence of adenosine, ketamine, and morphine on experimen-tally induced ischemic pain in healthy volunteers. An-esth. Analg. (1994) 79:787–791.
   PubMed Web of Science ®Google Scholar
• SEGERDAHL M, EKBLOM A, SJOLUND KF et al.: Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. NeuroReport (1995) 6:753–756.
   PubMed Web of Science ®Google Scholar
• EKBLOM A, SEGERDAHL M, SOLLEVI A: Adenosine in-creases the cutaneous heat pain threshold in healthy volunteers. Acta Anesth. Scand. (1995) 39:717–722.
   PubMed Web of Science ®Google Scholar
• CHOCA JI, PROUDFIT HK, GREEN RD: Identification of At and Ay adenosine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. (1987) 242:905–910.
   PubMed Web of Science ®Google Scholar
• GEIGER JD, NAGY JI: Distribution of adenosine deami-nase activity in rat brain and spinal cord. J. Neurosci. (1986) 6:2707–2714.
   PubMed Web of Science ®Google Scholar
• GEIGER JD, LABELLA FS, NAGY JL: Characterization and localization of adenosine receptors in rat spinal cord. Neurosci. (1984) 4:2303–2310.
   PubMed Web of Science ®Google Scholar
• GEIGER JD, NAGY JI: Localization of 3[11]-nitrobenzy-lthioinosine binding sites in rat spinal cord and pri-mary afferent neurons. Brain Res. (1985) 347:321–327.
   PubMed Web of Science ®Google Scholar
• SAWYNOK J, SWEENEY MI, WHITE TD: Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol (1986) 88:923–930.
   PubMed Web of Science ®Google Scholar
• REEVE AJ, DICKENSON AH: The roles of spinal adeno-sine receptors in the control of acute and more persis-tent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br. J. Pharmacol. (1995) 116:2221–2228.
   PubMed Web of Science ®Google Scholar
• BRUNDEGE JM, DUNWIDDIE TV: Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol. (1997) 39:353–391.
   PubMedGoogle Scholar
• ••A recent comprehensive and critical overview of the role ofadenosine as a neuromodulator.
   Google Scholar
• SJOLUND KF, SOLLEVI A, SEGERDAHL M, LUNDEBERG T: Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behav-ioural effects that suggest antinociception in rats. An-esth. Analg. (1997) 85:627–632.
   PubMed Web of Science ®Google Scholar
• DELANDER GE, WAHL JJ: Behaviour induced by putative nociceptive neurotransmitters is inhibited by adeno-sine or adenosine analogs coadministered intrathe-rally. J. Pharmacol Exp. Ther. (1988) 246:565–570.
   PubMed Web of Science ®Google Scholar
• LI E, PERL E: Adenosine inhibition of synaptic trans-mission in the substantia gelatinosa. J. Neurophysiol. (1994) 4:1611–1621.
   Google Scholar
• HERRICK-DAVIS K, CHIPPARI S, LUTTINGER D, WARD SJ: Evaluation of adenosine agonists as potential analge-sics. Eur. j Pharmacol. (1989) 162:365–369.
   PubMed Web of Science ®Google Scholar
• SAWYNOK J, REID A, POON A: Peripheral antinocicep-tive effect of an adenosine kinase inhibitor, with aug-mentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain (1998) 74:75–81.
   PubMed Web of Science ®Google Scholar
• FREDHOLM BB, DUNWIDDIE TV: How does adenosineinhibit transmitter release? Trends Pharmacol. Sci. (1988) 9:130–134.
   Google Scholar
• CRONSTEIN BN, NAIME D, FIRESTEIN G: The antiinflam-matory effects of an adenosine kinase inhibitor are mediated by adenosine. Arth. Rheum. (1995) 38:1040–1045.
   PubMed Web of Science ®Google Scholar
• FIRESTEIN GS: Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation. Drug Dev. Res. (1996) 39:371–376.
   Web of Science ®Google Scholar
• •Overview of the anti-inflammatory properties of adenosine and adenosine kinase inhibitors. First report of effects of AK inhibitor in rat adjuvant arthritis model.
   Google Scholar
• FIRESTEIN GS, BULLOUGH DA, ERION MD et al.: Inhibi-tion of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. j Im-munol. (1995) 154:326–334.
   PubMed Web of Science ®Google Scholar
• PARMELY MJ, ZHOU WW, EDWARDS CK etal.: Adenosine and a related carbocyclic nucleoside analogue selec-tively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immu-nol. (1993) 151:389–396.
   Google Scholar
• SAJJADI FG, TAKABAYASHI K, FOSTER AC, DOMINGO RC, FIRESTIEN GS: Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J. Immunol (1996) 156:3435–3442.
   PubMed Web of Science ®Google Scholar
• FIRESTEIN GS, BOYLE D, BULLOUGH DA et al.: Protectiveeffects of an adenosine kinase inhibitor in septic shock. J. Immunol. (1994) 152:5853–5859.
   PubMed Web of Science ®Google Scholar
• COTTAM HB, WASSON DB, SHIH HC et al.: New adeno-sine kinase inhibitors with oral anti-inflammatory ac-tivity: synthesis and biological evaluation. J. Med. Chem. (1993) 36:3424–3430.
   PubMed Web of Science ®Google Scholar
• ROSENGREN S, BONG GW, FIRESTEIN GS: Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leak-age. J. Immunol (1995) 154:5444–5451.
   PubMed Web of Science ®Google Scholar
• LESCH ME, FERIN MA, WRIGHT CD, SCHRIER DJ: The ef-fects of (R)-N-(1-methyl-2-phenylethyfi-adenosine PIA), a standard At-selective adenosine agonist, on rat acute models of inflammation and neutrophil func-tion. Agents Actions (1991) 34:25–27.
   PubMedGoogle Scholar
• SCHRIER DJ, LESCH ME, WRIGHT CD, GILBERTSON RB: The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflam-matory response in rats. J. Immunol. (1990) 145:1874–1879.
   PubMed Web of Science ®Google Scholar
• FIRESTEIN GS, PAINE MM, BOYLE DL: Mechanisms ofmethotrexate action in rheumatoid arthritis. Arth. Rheum. (1994) 37:193-200. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(4)
   Google Scholar
• CRONSTEIN BN, NAIME D, OSTAD E: The antiinflamma-tory mechanism of methotrexate. j Clin. Invest. (1993) 92:2675–2682.
   PubMed Web of Science ®Google Scholar
• BONG GW, ROSENGREN S, FIRESTEIN GS: Spinal cordadenosine receptor stimulation in rats inhibits dermal neutrophil accumulation: the role of N-methyl-n-aspa-nate receptors. J. Clin. Invest. (1996) 98:1–7.
   PubMed Web of Science ®Google Scholar
• WILLIAMS M: Progress towards purinoceptor basedtherapeutics. Curr. Opin. Invest. Drugs. (1993) 2:1105–1117.
   Google Scholar
• ARCH JRS, NEWSHOLME EA: The control of the metabo-lism and the hormonal role of adenosine. Essays Bio-chem. (1978) 14:82–123.
   PubMedGoogle Scholar
• DAVIES LP, JAMIESON DD, BAIRD-LAMBERT JA,KAZLAUSKAS R: Halogenated pyrrolopyrimidine ana-logues of adenosine from marine organisms: pharma-cological activities and potent inhibition of adenosine kinase. Biochem. Pharmacol. (1984) 33:347–355.
   PubMed Web of Science ®Google Scholar
• NEWBY AC, HOLMQUIST AC, ILLINGWORTH J, PEARSONJD: The control of adenosine concentration in poly-morphonuclear leukocytes, cultured cells and isolated perfused heart from the rat. Biochem. J. (1983) 214:317–323.
   PubMed Web of Science ®Google Scholar
• PAK MA, HAAS HL, DECKING UKM, SCHRADER J: Inhibi-tion of adenosine kinase increases endogenous adeno-sine and depresses neuronal activity in hippocampal slices. Neuropharmacology (1994) 33:1049–1053.
   PubMed Web of Science ®Google Scholar
• GOLEMBIOWSKA K, WHITE TD, SAWYNOK J: Adenosinekinase inhibitors augment release of adenosine from spinal cord slices. Eur.J. Phramacol (1996) 307:157–162.
   PubMed Web of Science ®Google Scholar
• BRITTON DR, MIKUSA J, LEE L, WILLIAMS M, KOWALUK E:Adenosine kinase inhibition enhances kainic acid-induced increases in striatal adenosine. AbsL Soc. Neu-roscL (1996) 22:1568.
   Google Scholar
• BELLFRAGE M, SOLLEVI A, SEGERDAHL M eta].: Systemicadenosine infusion alleviates spontaneous and stimu-lus evoked pain in patients with peripheral neuro-pathic pain. Anesth. Analg. (1995) 81:713–717.
   Google Scholar
• SEGERDAHL M, IRESTEDT L, SOLLEVI A: Antinociceptive effect of perioperative adenosine infusion in abdomi-nal hysterectomy. A cta Anesth. Scand. (1997) 41:180–185.
   Web of Science ®Google Scholar
• GARDNER CJ, TWISSEL DJ, COATES J, STRONG P: The ef-fects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat. Eur. Pharmacol. (1994) 257:117–124.
   PubMed Web of Science ®Google Scholar
• GUNGOR T, MALABRE P, TEULON JM et al.: N6-substituted adenosine receptor agonists. Synthesis and pharmacological activity as potent antinocicep-tive agents. J. Med. Chem. (1994) 37:4307–4316.
   Google Scholar
• JIANG J-L, VAN RHEE AM, MELMAN N, JI X-D, JACOBSON KA: 6-Phenyl-1,4-dihydropyridine derivatives as po-tent and selective A3 adenosine receptor antagonists. J. Med. Chem. (1996) 39:4667–4675.
   PubMed Web of Science ®Google Scholar
• ERION MD, WIESNER JB, DARE J, KOPCHO J, UGARKAR B: GP3269: an adenosine regulating agent with anticon-vulsant activity. Nucleosides Nucleotides Ther. Biol .Applic. (1996) 1 (Suppl 28).
   Google Scholar
• BERMAN RF, CORTESE B, WIESNER JB: Anticonvulsant activity of an adenosine kinase inhibitor, GP3269, against amygdala-kindled seizures in rats. AbsL Soc. NeuroscL (1997) 23:2162.
   Google Scholar
• WANG B, TANG J, WHITE PF et al: The effect of GP683, an adenosine kinase inhibitor, on the desflurane anes-thetic requirement in dogs. Anesth. Analg. (1997) 85:675–680.
   PubMed Web of Science ®Google Scholar
• KOWALUK EA, BANNON A, GUNTHER K et al: The effects of adenosine kinase (AK) inhibitors on acute thermal nociception. AbsL Soc. NeuroscL (1996) 22:617.6.
   Google Scholar
• CO WART M, BENNETT MJ, GFESSER G et al: SAR of a se-ries of nucleoside analogs as adenosine kinase inhibi-tors. 213th Meeting of the American Chemical Society (1997). Elizabeth A Kowaluk
   Google Scholar